Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Discs large homolog 1 (DLG1), also known as synapse-associated protein 97 (SAP97), is a multi-domain scaffolding protein belonging to the membrane-associated guanylate kinase (MAGUK) family. It plays a critical role in establishing and maintaining cell polarity, regulating cell-cell adhesion, and coordinating signal transduction pathways across various tissues. In the nervous system, DLG1 is involved in the trafficking and clustering of ionotropic glutamate receptors (such as AMPA and NMDA receptors) and potassium channels, thereby modulating synaptic plasticity and neuronal excitability.
In epithelial cells, it localizes to adherens junctions and acts as a tumor suppressor by interacting with the adenomatous polyposis coli (APC) protein to negatively regulate cell cycle progression. However, DLG1 can also exhibit oncogenic roles when subverted by viral oncoproteins (such as HPV E6 or Adenovirus E4-ORF1) or when overexpressed in certain malignancies like colorectal cancer, where it promotes cell migration and invasion. Although DLG1 is a highly attractive therapeutic target for cancer, immunological disorders, and neurological diseases, there are currently no approved drugs or clinical-stage small molecules that directly target this protein due to the challenges of targeting intracellular scaffolding proteins.
No approved drugs or clinical-stage small molecules currently target Discs large homolog 1. Experimental strategies focus on disrupting its PDZ domain-mediated protein-protein interactions or modulating its expression using RNA interference or intrabodies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Discs large homolog 1 (DLG1).